mGluR5 antagonists (Recordati)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NamemGluR5 antagonists (Recordati)
Drug Alias NameA/1140/31/12
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMetabotropic glutamate receptor 5 antagonists
TargetsMetabotropic glutamate receptor 5
Therapy Area/IndicationsCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRecordati Industria Chimica E Farmaceutica Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRecordati Industria Chimica E Farmaceutica Spa
Active IndicationsN/A
Inactive IndicationsCentral Nervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A